0000886163-17-000140.txt : 20171117 0000886163-17-000140.hdr.sgml : 20171117 20171117191954 ACCESSION NUMBER: 0000886163-17-000140 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171117 FILED AS OF DATE: 20171117 DATE AS OF CHANGE: 20171117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAMATTINA JOHN L CENTRAL INDEX KEY: 0001216074 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 171212376 MAIL ADDRESS: STREET 1: 81 WYMAN ST STREET 2: POST OFFICE BOX 9046 CITY: WALTHAM STATE: MA ZIP: 02454 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2017-11-17 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001216074 LAMATTINA JOHN L 3911 SORRENTO VALLEY BOULEVARD, STE 110 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2017-11-17 4 M 0 4000 10.12 A 24956 D Common Stock 2017-11-17 4 S 0 4000 139.79 D 20956 D Non-Qualified Stock Option (right to buy) 10.12 2017-11-17 2017-11-17 4 M 0 4000 0.0 D 2021-06-01 Common Stock 4000 3335 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.75 to $139.79, inclusive. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 01, 2011, and will fully vest on the first anniversary of the grant date. By: Charles S. Berkman For: John L. LaMattina 2017-11-17